| |
|
GRAMEEN BANK
Cash Flow Statement
For the year ended 31 December 2009
|
| |
| |
Notes |
|
2009
Taka |
|
2008
Taka |
| |
| CASH FLOW FROM OPERATING ACTIVITIES |
|
|
|
|
| |
Interest received |
|
|
13,304,538,950 |
|
10,082,511,169 |
| |
Interest paid |
|
|
(7,066,648,581) |
|
(5,458,778,463) |
| |
Cash payments to employees |
|
|
(3,823,151,724) |
|
(2,955,496,895) |
| |
Payments for other operating expenses |
|
|
(1,732,309,921) |
|
(1,351,302,671) |
| |
Receipts from other operating income |
|
|
408,453,977 |
|
417,065,556 |
| |
Recoveries from loans previously written off |
|
|
336,701,083 |
|
505,643,663 |
| Operating profit before changes in operating assets and liabilities |
|
|
1,427,583,784 |
|
1,239,642,359 |
| |
|
|
|
|
|
|
| (Increase)/decrease in operating assets: |
|
|
|
|
|
| |
Loans and advances |
|
|
(10,572,071,111) |
|
(8,240,478,178) |
| |
Other assets |
27 |
|
(30,137,934) |
|
92,301,712 |
| |
|
|
|
|
|
|
| Increase/(decrease) in operating liabilities: |
|
|
|
|
|
| |
Deposits and other funds |
|
|
18,952,244,232 |
|
12,659,293,592 |
| |
Other liabilities |
28 |
|
(434,485,878) |
|
(197,472,976) |
| Net cash from operating activities |
|
|
9,343,133,093 |
|
5,553,286,509 |
| |
|
|
|
|
|
|
| CASH FLOW FROM INVESTING ACTIVITIES |
|
|
|
|
|
| |
Purchase of tangible fixed assets |
|
|
(248,232,726) |
|
(101,613,769) |
| |
Proceeds from sale of tangible fixed assets |
|
|
8,696,681 |
|
(13,214,005) |
| |
Investments in FDR |
|
|
(9,020,427,420) |
|
(4,264,494,535) |
| Net cash used in investing activities |
|
|
(9,259,963,465) |
|
(4,379,322,309) |
| |
|
|
|
|
|
|
| CASH FLOW FROM FINANCING ACTIVITIES |
|
|
|
|
|
| |
Issue of share capital |
|
|
165,949,300 |
|
40,000,000 |
| |
Net decrease in borrowings from banks and other institution |
|
|
(62,057,932) |
|
(62,057,933) |
| |
Payment of dividends |
|
|
(107,400,000) |
|
(63,600,000) |
| |
Payment of tax on dividends |
|
|
(10,560,000) |
|
(6,240,000) |
| |
Payment to GB borrowers' investments trust |
|
|
(101,128,400) |
|
(690,005,600) |
| Net cash used in financing activities |
|
|
(115,197,032) |
|
(781,903,533) |
| |
|
|
|
|
|
|
| Net Increase/(decrease) in cash and cash equivalents |
|
|
(32,027,404) |
|
392,060,667 |
| Cash and cash equivalents at beginning of the period |
|
|
1,328,458,447 |
|
936,397,780 |
| Cash and cash equivalents at end of the period |
29 |
|
1,296,431,043 |
|
1,328,458,447 |
| |
|
|
|
|
|
|
| |
|
The annexed notes 1 to 29 form an integral part of these financial statements.
|
| |
|
|
|
|
|
|
(M. Shahjahan)
General Manager |
|
Director |
|
Director |
|
(Dr. Muhammad Yunus)
Managing Director |
| |
|
|
|
|
|
|
A. Qasem & Co.
Chartered Accountants |
|
ACNABIN
Chartered Accountants |
| |
|
|
|
|
|
|
Dated, Dhaka
March 30, 2010 |
|
|
|
|
|
|
